These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8731310)

  • 21. Hyperleptinemia--non-haemodynamic risk factor for the left ventricular hypertrophy development in hypertensive overweight females.
    Selthofer-Relatić K; Radić R; Vizjak V; Vcev A; Kosović P; Bosnjak I; Selthofer R
    Coll Antropol; 2008 Sep; 32(3):681-5. PubMed ID: 18982737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and clinical correlates of right ventricular hypertrophy in essential hypertension.
    Cuspidi C; Negri F; Giudici V; Valerio C; Meani S; Sala C; Esposito A; Masaidi M; Zanchetti A; Mancia G
    J Hypertens; 2009 Apr; 27(4):854-60. PubMed ID: 19516183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Association between angiotensin converting enzyme gene, chymase gene and regression of left ventricular hypertrophy in patients treated with angiotensin converting enzyme inhibitors].
    He H; Li LM; Cao WH; Liu MZ; Sun NL; Lü J; Hu YH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):756-60. PubMed ID: 15555355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [QT dispersion intervals in hypertensives with left ventricular hypertrophy].
    Ghanem Wisam MA; Murín J; Jaber J; Radman A; Bulas J; Kozliková K
    Vnitr Lek; 2001 Jan; 47(1):20-4. PubMed ID: 15635864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between some humoral factors and left ventricular hypertrophy in essential hypertension.
    Hui Y; Hao Y; Chen X; Jing S; Dai Z
    Chin Med J (Engl); 1996 Nov; 109(11):885-7. PubMed ID: 9275376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Asymmetric septal hypertrophy in essential hypertension and sympathetic nervous system].
    Kumagai E; Nomura G; Midorikawa K; Koga Y
    Kokyu To Junkan; 1983 Jan; 31(1):63-6. PubMed ID: 6222450
    [No Abstract]   [Full Text] [Related]  

  • 27. Electrocardiographic left ventricular hypertrophy and arterial stiffness: the Ohasama study.
    Watabe D; Hashimoto J; Hatanaka R; Hanazawa T; Ohba H; Ohkubo T; Kikuya M; Totsune K; Imai Y
    Am J Hypertens; 2006 Dec; 19(12):1199-205. PubMed ID: 17161763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The lipoprotein lipase gene serine 447 stop variant influences hypertension-induced left ventricular hypertrophy and risk of coronary heart disease.
    Talmud PJ; Flavell DM; Alfakih K; Cooper JA; Balmforth AJ; Sivananthan M; Montgomery HE; Hall AS; Humphries SE
    Clin Sci (Lond); 2007 Jun; 112(12):617-24. PubMed ID: 17291198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Myocardial hypertrophy in rabbits with vasorenal arterial hypertension during pharmacological blockade of formation of angiotensin II and its interaction with specific receptors].
    Frolov VA; Drozdova GA; Mustiatsa VF; Balaev VV; Rieger P
    Biull Eksp Biol Med; 1999 May; 127(5):506-9. PubMed ID: 10399566
    [No Abstract]   [Full Text] [Related]  

  • 30. [Relation between hemodynamics of the major and minor circulatory systems and hypertrophy of the left ventricle in the echocardiographic examination in hypertension].
    Jandová R; Niederle P; Widimský J
    Vnitr Lek; 1983 Sep; 29(9):851-61. PubMed ID: 6227127
    [No Abstract]   [Full Text] [Related]  

  • 31. Cardiac hypertrophy in hypertension: relation to 24-h blood pressure profile and arterial stiffness.
    Lekakis JP; Zakopoulos NA; Protogerou AD; Kotsis VT; Papaioannou TG; Stamatelopoulos KS; Tsitsiricos MD; Pitiriga VCh; Papamichael CM; Toumanides ST; Mavrikakis ME
    Int J Cardiol; 2004 Oct; 97(1):29-33. PubMed ID: 15336803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mortality rate in patients receiving "diet pills".
    Asher WL
    Curr Ther Res Clin Exp; 1972 Aug; 14(8):525-39. PubMed ID: 4629314
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of metabolic syndrome on left ventricular mass: is the same in all ethnic groups and in men and women?
    Celik T; Iyisoy A; Dogru MT; Isik E
    Int J Cardiol; 2009 Jan; 131(3):395-6; author reply 396-7. PubMed ID: 17689759
    [No Abstract]   [Full Text] [Related]  

  • 34. [Obesity, remodeling of the heart and its morpho-functional changes. Controversial problems].
    Peretolchina TF; Dashutina SIu; Barats SS
    Kardiologiia; 2005; 45(7):66-8. PubMed ID: 16091665
    [No Abstract]   [Full Text] [Related]  

  • 35. [Mild arterial hypertension: what, beyond the numbers?].
    Francischetti EA; Fagundes VG; Oigman W
    Arq Bras Cardiol; 1989 Jun; 52(6):349-65. PubMed ID: 2532498
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiac hypertrophy. Mechanical, neural, and endocrine dependence.
    Morgan HE; Baker KM
    Circulation; 1991 Jan; 83(1):13-25. PubMed ID: 1824620
    [No Abstract]   [Full Text] [Related]  

  • 37. [Symposium on problems of essential arterial hypertension. Etiopathogenesis of essential hypertension].
    García Torres JA
    Rev Esp Cardiol; 1968 Jan; 21(1):3-18. PubMed ID: 4299631
    [No Abstract]   [Full Text] [Related]  

  • 38. [Response to epinephrine in myocardial hypertrophy].
    Itaie M; Ifuku M; Tomimasu K; Osada K; Itaie K
    Kokyu To Junkan; 1983 Nov; 31(11):1181-5. PubMed ID: 6233684
    [No Abstract]   [Full Text] [Related]  

  • 39. Cellular and signaling mechanisms of cardiac hypertrophy.
    Piano MR
    J Cardiovasc Nurs; 1994 Jul; 8(4):1-26. PubMed ID: 7931462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Left ventricular hypertrophy in young patients with borderline hypertension].
    Noda H; Fujita T
    Nihon Naika Gakkai Zasshi; 1987 Aug; 76(8):1211-7. PubMed ID: 2960765
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.